Skip Nav Destination
Issues
15 January 2021
-
Cover Image
Cover Image
The cover shows a biopsy from a patient with metastatic non-small cell lung cancer with a cryptic EML4-ALK fusion. This fusion was not detected by ALK IHC and FISH due to the complex nature of the rearrangement; however, whole genome sequencing and RNA-seq identified the variant, and the patient had an excellent response to crizotinib. For details, see the article by Tsang and colleagues on page 522 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Reviews
Author Choice
Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration—Melanoma Research Alliance Public Workshop
Kristen L. Mueller; Marc R. Theoret; Steven J. Lemery; Laleh Amiri-Kordestani; Charlotte E. Ariyan; Michael B. Atkins; Donald A. Berry; Christian U. Blank; Angela M. DeMichele; Patrick M. Forde; Nageatte Ibrahim; Patricia Keegan; Tara C. Mitchell; Rebecca A. Moss; Caroline Robert; Rajeshwari Sridhara; Janis M. Taube; Michael T. Tetzlaff; Jennifer A. Wargo; Keith T. Flaherty; Michael J. Kaplan; Suzanne L. Topalian; Ashley F. Ward; Marc S. Hurlbert
Clinical Trial Brief Report
Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial
Conrad-Amadeus Voltin; Jasmin Mettler; Lutz van Heek; Helen Goergen; Horst Müller; Christian Baues; Ulrich Keller; Julia Meissner; Karolin Trautmann-Grill; Andrea Kerkhoff; Michael Fuchs; Stephanie Sasse; Bastian von Tresckow; Markus Dietlein; Peter Borchmann; Andreas Engert; Carsten Kobe; Paul J. Bröckelmann
Clinical Trials: Targeted Therapy
Author Choice
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
Yen-Shen Lu; Keun Seok Lee; Tsu-Yi Chao; Ling-Ming Tseng; Imjai Chitapanarux; Shin-Cheh Chen; Chien-Ting Liu; Joohyuk Sohn; Jee Hyun Kim; Yuan-Ching Chang; Youngsen Yang; Kanjana Shotelersuk; Kyung Hae Jung; Roberta Valenti; Cassandra Slader; Melissa Gao; Yeon Hee Park
Phase Ib Study of Ribociclib plus Fulvestrant and Ribociclib plus Fulvestrant plus PI3K Inhibitor (Alpelisib or Buparlisib) for HR+ Advanced Breast Cancer
Sara M. Tolaney; Young-Hyuck Im; Emiliano Calvo; Yen-Shen Lu; Erika Hamilton; Andres Forero-Torres; Thomas Bachelot; Michela Maur; Angelica Fasolo; Ralph Tiedt; Lisa Nardi; Uz Stammberger; Ahmed M. Abdelhady; Shiling Ruan; Soo Chin Lee
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response
Fatima Karzai; Stephanie M. Walker; Scott Wilkinson; Ravi A. Madan; Joanna H. Shih; Maria J. Merino; Stephanie A. Harmon; David J. VanderWeele; Lisa M. Cordes; Nicole V. Carrabba; John R. Bright; Nicolas T. Terrigino; Guinevere Chun; Marijo Bilusic; Anna Couvillon; Amy Hankin; Monique N. Williams; Rosina T. Lis; Huihui Ye; Peter L. Choyke; James L. Gulley; Adam G. Sowalsky; Baris Turkbey; Peter A. Pinto; William L. Dahut
Author Choice
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma
Antoine Hollebecque; Stefania Salvagni; Ruth Plummer; Nicolas Isambert; Patricia Niccoli; Jaume Capdevila; Giuseppe Curigliano; Victor Moreno; Patricia Martin-Romano; Eric Baudin; Marina Arias; Sheila Mora; Juan de Alvaro; Jorge Di Martino; Josep L. Parra-Palau; Tania Sánchez-Pérez; Ida Aronchik; Ellen H. Filvaroff; Manisha Lamba; Zariana Nikolova; Johann S. de Bono
Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA-Mutant Cancers
Komal Jhaveri; Matthew T. Chang; Dejan Juric; Cristina Saura; Valentina Gambardella; Anton Melnyk; Manish R. Patel; Vincent Ribrag; Cynthia X. Ma; Raid Aljumaily; Philippe L. Bedard; Jasgit C. Sachdev; Lara Dunn; Helen Won; John Bond; Surai Jones; Heidi M. Savage; Maurizio Scaltriti; Timothy R. Wilson; Michael C. Wei; David M. Hyman
Clinical Trials: Immunotherapy
Author Choice
OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors
Martin Gutierrez; Victor Moreno; Kimberley M. Heinhuis; Anthony J. Olszanski; Anna Spreafico; Michael Ong; Quincy Chu; Richard D. Carvajal; José Trigo; Maria Ochoa de Olza; Mariano Provencio; Filip Yves De Vos; Filippo De Braud; Stephen Leong; Deanne Lathers; Rui Wang; Palani Ravindran; Yan Feng; Praveen Aanur; Ignacio Melero
Precision Medicine and Imaging
Circulating T-cell Immunosenescence in Patients with Advanced Non–small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Roberto Ferrara; Marie Naigeon; Edouard Auclin; Boris Duchemann; Lydie Cassard; Jean-Mehdi Jouniaux; Lisa Boselli; Jonathan Grivel; Aude Desnoyer; Laura Mezquita; Matthieu Texier; Caroline Caramella; Lizza Hendriks; David Planchard; Jordi Remon; Sabina Sangaletti; Claudia Proto; Marina C. Garassino; Jean-Charles Soria; Aurelien Marabelle; Anne-Laure Voisin; Siham Farhane; Benjamin Besse; Nathalie Chaput
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the SOLE Trial
Elena Guerini-Rocco; Kathryn P. Gray; Caterina Fumagalli; Marta Rita Reforgiato; Isabella Leone; Paola Rafaniello Raviele; Elisabetta Munzone; Roswitha Kammler; Patrick Neven; Erika Hitre; Guy Jerusalem; Edda Simoncini; Andrea Gombos; Ines Deleu; Per Karlsson; Stefan Aebi; Jacquie Chirgwin; Vincenzo Di Lauro; Alastair Thompson; Marie-Pascale Graas; Matthew Barber; Christel Fontaine; Sibylle Loibl; Joaquín Gavilá; Katsumasa Kuroi; Bettina Müller; Seamus O’Reilly; Angelo Di Leo; Aron Goldhirsch; Giuseppe Viale; Massimo Barberis; Meredith M. Regan; Marco Colleoni
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
Alfredo Rivas-Delgado; Ferran Nadeu; Anna Enjuanes; Sebastián Casanueva-Eliceiry; Pablo Mozas; Laura Magnano; Natalia Castrejón de Anta; Jordina Rovira; Ivan Dlouhy; Silvia Martín; Miguel Osuna; Sonia Rodríguez; Marc Simó; Magda Pinyol; Tycho Baumann; Silvia Beà; Olga Balagué; Julio Delgado; Neus Villamor; Xavier Setoain; Elías Campo; Eva Giné; Armando López-Guillermo
Uncovering Clinically Relevant Gene Fusions with Integrated Genomic and Transcriptomic Profiling of Metastatic Cancers
Erica S. Tsang; Cameron J. Grisdale; Erin Pleasance; James T. Topham; Karen Mungall; Caralyn Reisle; Caleb Choo; Marcus Carreira; Reanne Bowlby; Joanna M. Karasinska; Daniel MacMillan; Laura M. Williamson; Eric Chuah; Richard A. Moore; Andrew J. Mungall; Yongjun Zhao; Basile Tessier-Cloutier; Tony Ng; Sophie Sun; Howard J. Lim; David F. Schaeffer; Daniel J. Renouf; Stephen Yip; Janessa Laskin; Marco A. Marra; Steven J.M. Jones; Jonathan M. Loree
Translational Cancer Mechanisms and Therapy
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy
Brian H. Santich; Sarah M. Cheal; Mahiuddin Ahmed; Michael R. McDevitt; Ouathek Ouerfelli; Guangbin Yang; Darren R. Veach; Edward K. Fung; Mitesh Patel; Daniela Burnes Vargas; Aiza A. Malik; Hong-Fen Guo; Pat B. Zanzonico; Sebastien Monette; Adam O. Michel; Charles M. Rudin; Steven M. Larson; Nai K. Cheung
Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity
Bangxing Hong; Valerie Chapa; Uksha Saini; Puneet Modgil; David E. Cohn; Guangan He; Zahid H. Siddik; Anil K. Sood; Yuanqing Yan; Karuppaiyah Selvendiran; Guangsheng Pei; Zhongming Zhao; Ji Young Yoo; Balveen Kaur
Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer
Adam R. Wolfe; Ryan Robb; Ahmad Hegazi; Laith Abushahin; Linlin Yang; Duan-Liang Shyu; Jose G. Trevino; Zobeida Cruz-Monserrate; John R. Jacob; Kamalakannan Palanichamy; Arnab Chakravarti; Terence M. Williams
Author Choice
Characterizing CDK12-Mutated Prostate Cancers
Pasquale Rescigno; Bora Gurel; Rita Pereira; Mateus Crespo; Jan Rekowski; Mattia Rediti; Maialen Barrero; Joaquin Mateo; Diletta Bianchini; Carlo Messina; Maria D. Fenor de la Maza; Khobe Chandran; Juliet Carmichael; Christina Guo; Alec Paschalis; Adam Sharp; George Seed; Ines Figueiredo; Maryou Lambros; Susana Miranda; Ana Ferreira; Claudia Bertan; Ruth Riisnaes; Nuria Porta; Wei Yuan; Suzanne Carreira; Johann S. de Bono
Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome
Beata Wolska-Kusnierz; Agata Pastorczak; Wojciech Fendler; Anna Wakulinska; Bozena Dembowska-Baginska; Edyta Heropolitanska-Pliszka; Barbara Piątosa; Barbara Pietrucha; Krzysztof Kałwak; Marek Ussowicz; Anna Pieczonka; Katarzyna Drabko; Monika Lejman; Sylwia Koltan; Jolanta Gozdzik; Jan Styczynski; Alina Fedorova; Natalia Miakova; Elena Deripapa; Larysa Kostyuchenko; Zdenka Krenova; Eva Hlavackova; Andrew R. Gennery; Karl-Walter Sykora; Sujal Ghosh; Michael H. Albert; Dmitry Balashov; Mary Eapen; Peter Svec; Markus G. Seidel; Sara S. Kilic; Agnieszka Tomaszewska; Ewa Wiesik-Szewczyk; Alexandra Kreins; Johann Greil; Jochen Buechner; Bendik Lund; Hanna Gregorek; Krystyna Chrzanowska; Wojciech Mlynarski
Author Choice
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor–Positive Breast Cancers
Reema S. Wahdan-Alaswad; Susan M. Edgerton; Hiba Salem; Hyun Min Kim; Aik Choon Tan; Jessica Finlay-Schultz; Elizabeth A. Wellberg; Carol A. Sartorius; Britta M. Jacobsen; Bryan R. Haugen; Bolin Liu; Ann D. Thor
BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia
Haley E. Ramsey; Dalton Greenwood; Susu Zhang; Merrida Childress; Maria P. Arrate; Agnieszka E. Gorska; Londa Fuller; Yue Zhao; Kristy Stengel; Melissa A. Fischer; Matthew C. Stubbs; Phillip C.C. Liu; Kelli Boyd; Jeffrey C. Rathmell; Scott W. Hiebert; Michael R. Savona
Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses
David H. Aggen; Casey R. Ager; Aleksandar Z. Obradovic; Nivedita Chowdhury; Ali Ghasemzadeh; Wendy Mao; Matthew G. Chaimowitz; Zoila A. Lopez-Bujanda; Catherine S. Spina; Jessica E. Hawley; Matthew C. Dallos; Cheng Zhang; Vinson Wang; Hu Li; Xinzheng V. Guo; Charles G. Drake
Development of Highly Optimized Antibody–Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia
Yoon-Chi Han; Jennifer Kahler; Nicole Piché-Nicholas; Wenyue Hu; Stephane Thibault; Fan Jiang; Mauricio Leal; Madan Katragadda; Andreas Maderna; Russell Dushin; Nadira Prashad; Manoj B. Charati; Tracey Clark; L. Nathan Tumey; Xingzhi Tan; Andreas Giannakou; Edward Rosfjord; Hans-Peter Gerber; Lioudmila Tchistiakova; Frank Loganzo; Christopher J. O'Donnell; Puja Sapra
Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion
Christian Watermann; Helen Pasternack; Christian Idel; Julika Ribbat-Idel; Johannes Brägelmann; Patrick Kuppler; Anne Offermann; Danny Jonigk; Mark Philipp Kühnel; Andreas Schröck; Eva Dreyer; Christian Rosero; Jacqueline Nathansen; Anna Dubrovska; Lars Tharun; Jutta Kirfel; Barbara Wollenberg; Sven Perner; Rosemarie Krupar
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP–negative Glioblastoma
Anna Esteve-Codina; Francesc Alameda; Cristina Carrato; Estela Pineda; Oriol Arpí; Maria Martinez-García; Mar Mallo; Marta Gut; Marc Dabad; Avelina Tortosa; Sonia Del Barco; Jaume Capellades; Josep Puig; Oscar Gallego; Teresa Pujol; Laura Oleaga; Miquel Gil-Gil; Cristian de Quintana-Schmidt; Izaskun Valduvieco; Anna Martinez-Cardús; Beatriz Bellosillo; Ana Maria Muñoz-Marmol; Anna Esteve; Marta Domenech; Angels Camins; Jordi Craven-Bartle; Salvador Villa; Jordi Marruecos; Sira Domenech; Nuria de la Iglesia; Carmen Balana
Advertisement
